The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Long-acting beta<sub>2</sub>-agonist in addition to tiotropium versus either tiotropium or long-acting beta<sub>2</sub>-agonist alone for chronic obstructive pulmonary disease
|
|---|---|
| Published by |
John Wiley & Sons, Ltd, April 2012
|
| DOI | 10.1002/14651858.cd008989.pub2 |
| Pubmed ID | |
| Authors |
Karner, Charlotta, Cates, Christopher J |
| Abstract |
Long-acting bronchodilators comprising long-acting beta(2)-agonists and the anticholinergic agent tiotropium are commonly used for managing persistent symptoms of chronic obstructive pulmonary disease. Combining these treatments, which have different mechanisms of action, may be more effective than the individual components. However, the benefits and risks of combining tiotropium and long-acting beta(2)-agonists for the treatment of chronic obstructive pulmonary (COPD) disease are unclear. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 33% |
| United States | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Scientists | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Chile | 1 | 1% |
| Colombia | 1 | 1% |
| Unknown | 92 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 20 | 21% |
| Researcher | 14 | 15% |
| Other | 12 | 13% |
| Student > Bachelor | 10 | 11% |
| Student > Postgraduate | 7 | 7% |
| Other | 16 | 17% |
| Unknown | 15 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 46 | 49% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 10% |
| Nursing and Health Professions | 9 | 10% |
| Biochemistry, Genetics and Molecular Biology | 3 | 3% |
| Agricultural and Biological Sciences | 2 | 2% |
| Other | 7 | 7% |
| Unknown | 18 | 19% |